Aurora Cannabis Inc. (ACB)
Nasdaq · Healthcare · Drug Manufacturers - Specialty & Generic
$4.46+13.78%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $282M
- 52-week range
- $2.56 – $6.67
- 52-week change
- −32.53%
- EPS (trailing)
- −$0.61
- Analyst rating
- 2.2 Buy
- Next earnings
- Nov 4, 2026
About Aurora Cannabis Inc.
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. The company also engages in pharmacy activities. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.
Headquarters: Edmonton, Canada · 1,028 employees · auroramj.com